(Q44619585)

English

Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism

scientific article published on 24 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism (English)

1 reference

Europe PubMed Central

4 December 2017

1 reference

based on heuristic

inferred from title

hypogonadotropic hypogonadism

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

4 December 2017

author name string

G Tirabassi

1

1 reference

Europe PubMed Central

4 December 2017

N delli Muti

2

1 reference

Europe PubMed Central

4 December 2017

A Gioia

3

1 reference

Europe PubMed Central

4 December 2017

A Biagioli

4

1 reference

Europe PubMed Central

4 December 2017

G Balercia

6

1 reference

Europe PubMed Central

4 December 2017

publication date

24 January 2014

1 reference

Europe PubMed Central

4 December 2017

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

4 December 2017

37

1 reference

Europe PubMed Central

4 December 2017

4

1 reference

Europe PubMed Central

4 December 2017

393-400

1 reference

Europe PubMed Central

4 December 2017

https://scigraph.springernature.com/pub.10.1007/s40618-014-0052-2

0 references

A crosstalk between bone and gonads.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Testosterone and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Onset of effects of testosterone treatment and time span until maximum effects are achieved

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Sex hormones and bone health in males

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Have androgen receptor gene CAG and GGC repeat polymorphisms an effect on sperm motility in infertile men?

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

The CAG repeat polymorphism within the androgen receptor gene and maleness

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Regulation of bone mass by growth hormone

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Testing growth hormone deficiency in adults

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Clinical Review#: The diagnosis and management of central hypoadrenalism

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Bone mass and the CAG and GGN androgen receptor polymorphisms in young men.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Adult GH deficiency throughout lifetime

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Sexual dysfunctions in men affected by autoimmune Addison's disease before and after short-term gluco- and mineralocorticoid replacement therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Isolated corticotrophin deficiency

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Altered bone mineral density in patients with complete androgen insensitivity syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Bone mineral density in the complete androgen insensitivity and 5alpha-reductase-2 deficiency syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

CAG repeat testing of androgen receptor polymorphism: is this necessary for the best clinical management of hypogonadism?

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Aerobic exercise and bone mineral density in middle-aged finnish men: a controlled randomized trial with reference to androgen receptor, aromatase, and estrogen receptor α gene polymorphisms

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Association between repeat length of exon 1 CAG microsatellite in the androgen receptor and bone density in men is modulated by sex hormone levels

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0052-2

21 January 2018

Effect of testosterone treatment on bone mineral density in men over 65 years of age.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24458833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24458833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgens and bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/24458833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of imaging in the diagnosis and management of complete androgen insensitivity syndrome in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/24458833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and pseudo-Cushing state: a comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24458833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoporosis in men

1 reference

https://pubmed.ncbi.nlm.nih.gov/24458833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24458833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Actions of thyroid hormones in bone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24458833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40618-014-0052-2

1 reference

Europe PubMed Central

4 December 2017

release_4ac7kmcckremznir3ruxlctk54

1 reference

https://api.fatcat.wiki/v0/release/4ac7kmcckremznir3ruxlctk54

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44619585&oldid=2029530501"